We analyzed data from two clinical trials involving 579 individuals with Irritable Bowel Syndrome (IBS) to determine how CNCM I-3856 affects symptoms like bloating.
Our findings revealed that during the second month of supplementation, participants experienced significant reductions in both abdominal pain and bloating—up to 14.9% compared to those taking a placebo.
While intestinal symptoms improved, there were no significant differences observed between groups at the end of treatment. However, stool consistency was notably better in those taking CNCM I-3856.
Read More
We analyzed the effectiveness of sacrosidase from Saccharomyces cerevisiae in reducing gastrointestinal symptoms, including bloating, in children with congenital sucrase-isomaltase deficiency (CSID).
In a randomized, double-blind trial involving 28 children, results indicated that sacrosidase effectively minimized diarrhea, abdominal cramps, gas, and bloating, particularly when consumed alongside a regular diet.
By measuring symptoms and daily stool counts over several phases, we found sacrosidase to be a safe and effective option for managing CSID symptoms.
Read More
Sourdough improves stomach comfortPostprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults.
Study highlights dietary options.
We examined how sourdough baked goods affect bloating and other gastrointestinal symptoms in healthy adults. Using a double-blind, randomized crossover method, we served participants either sourdough or brewer's yeast croissants and monitored gastric emptying and hydrogen production.
The results suggested that sourdough may promote better gastrointestinal function and be more tolerable compared to brewer's yeast products. This indicates that switching to sourdough could alleviate some post-meal discomfort, including bloating.
Read More
Yeast treatment shows mixed resultsA yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial.
Moderate relevance to gastrointestinal health
We investigated the effects of EpiCor fermentate on gastrointestinal discomfort and constipation, focusing on bloating. In a randomized double-blind trial, eighty participants tracked their symptoms over six weeks, comparing a yeast-based treatment to a placebo. While the results showed that EpiCor could positively influence gut microbiome composition and improve constipation symptoms, there was no significant direct benefit reported for bloating relief. So, while EpiCor can help with certain bowel issues, its effectiveness may not extend to all gastrointestinal discomforts.
Read More
Saccharomyces cerevisiae shows potentialRandomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation.
Suggests further targeted research needed
We conducted a randomized, double-blind, placebo-controlled trial with 379 individuals diagnosed with irritable bowel syndrome (IBS) to investigate the effects of Saccharomyces cerevisiae (S. cerevisiae) on bloating and other symptoms.
Although the overall results showed no significant improvement in intestinal pain or discomfort for all IBS patients, we observed promising results in those with constipation. This subgroup experienced notable relief from bloating and abdominal pain, highlighting the need for further research in this area.
Read More